stoxline Quote Chart Rank Option Currency Glossary
AEON Biopharma, Inc. (AEON)
1.36  -0.15 (-9.93%)    06-13 16:00
Open: 1.54
High: 1.54
Volume: 41,151
Pre. Close: 1.51
Low: 1.36
Market Cap: 53(M)
Technical analysis
2024-06-13 4:41:23 PM
Short term     
Mid term     
Targets 6-month :  2.06 1-year :  2.42
Resists First :  1.76 Second :  2.07
Pivot price 1.55
Supports First :  1.25 Second :  1.04
MAs MA(5) :  1.5 MA(20) :  1.58
MA(100) :  7.07 MA(250) :  0
MACD MACD :  -0.6 Signal :  -0.7
%K %D K(14,3) :  23.6 D(3) :  29.4
RSI RSI(14): 32.3
52-week High :  17.17 Low :  1.25
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ AEON ] has closed above bottom band by 7.8%. Bollinger Bands are 89.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.54 - 1.55 1.55 - 1.56
Low: 1.34 - 1.35 1.35 - 1.36
Close: 1.34 - 1.36 1.36 - 1.37
Company Description

AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.

Headline News

Fri, 31 May 2024
AEON Biopharma (NASDAQ:AEON) Receives Buy Rating from HC Wainwright - Defense World

Thu, 30 May 2024
AEON Biopharma (NASDAQ:AEON) Given Buy Rating at HC Wainwright - MarketBeat

Wed, 29 May 2024
AEON Biopharma announces restructuring and cost cuts By -

Wed, 29 May 2024
Aeon Biopharma to Slash Workforce in Half - Orange County Business Journal

Wed, 29 May 2024
Down -64.16% in 4 Weeks, Here's Why AEON Biopharma, Inc. (AEON) Looks Ripe for a Turnaround - Yahoo Finance

Fri, 03 May 2024
Aeon Biopharma Plunges on Phase 2 Results - Orange County Business Journal

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 37 (M)
Shares Float 14 (M)
Held by Insiders 41.8 (%)
Held by Institutions 22.7 (%)
Shares Short 55 (K)
Shares Short P.Month 63 (K)
Stock Financials
EPS -2.4
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -3.28
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -172.9 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -1.52
Qtrly Earnings Growth 0 %
Operating Cash Flow -45 (M)
Levered Free Cash Flow -22 (M)
Stock Valuations
PE Ratio -0.57
PEG Ratio 0
Price to Book value -0.42
Price to Sales 0
Price to Cash Flow -1.12
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android